145 related articles for article (PubMed ID: 30535610)
1. An Interesting Case of Carbamazepine-Induced Stevens-Johnson Syndrome.
Masuka JT; Muzopambwa G; Khoza S; Chibanda D
Drug Saf Case Rep; 2018 Dec; 6(1):1. PubMed ID: 30535610
[TBL] [Abstract][Full Text] [Related]
2. Stevens-Johnson syndrome-toxic epidermal necrolysis (SJS-TEN) overlap associated with carbamazepine use.
Suresh Kumar PN; Thomas B; Kumar K; Kumar S
Indian J Psychiatry; 2005 Apr; 47(2):121-3. PubMed ID: 20711297
[TBL] [Abstract][Full Text] [Related]
3. Severe carbamazepine-induced cutaneous reaction in the treatment of post-herpetic neuralgia. Case report.
Garcia JB; Ferro LS; Carvalho AB; da Rocha RM; de Souza LM
Rev Bras Anestesiol; 2010; 60(4):429-37. PubMed ID: 20659616
[TBL] [Abstract][Full Text] [Related]
4. Stevens-Johnson syndrome progressing to toxic epidermal necrolysis with haloperidol and carbamazepine combination.
Kumar A; Sarkar S; Praharaj SK; Akhtar S; Diwakar M
Ind Psychiatry J; 2011 Jul; 20(2):131-3. PubMed ID: 23271869
[TBL] [Abstract][Full Text] [Related]
5. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
[TBL] [Abstract][Full Text] [Related]
6. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.
Frey N; Bodmer M; Bircher A; Rüegg S; Jick SS; Meier CR; Spoendlin J
Epilepsia; 2017 Dec; 58(12):2178-2185. PubMed ID: 29027197
[TBL] [Abstract][Full Text] [Related]
7. Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepine-induced Stevens-Johnson syndrome.
Huang LY; Liao WC; Chiou CC; Lou JP; Hu P; Ko FC
J Formos Med Assoc; 2007 Dec; 106(12):1032-7. PubMed ID: 18194909
[TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson Syndrome Associated With Chlordiazepoxide.
Jawaro T; Kumar A; Pistun O; Dixit D
J Pharm Technol; 2018 Apr; 34(2):82-85. PubMed ID: 34860942
[No Abstract] [Full Text] [Related]
9. Drug-induced Stevens-Johnson syndrome: case series from tertiary care centre in Gujarat.
Bang D; Shah T; Thakker D; Shah Y; Raval AD
Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):384-95. PubMed ID: 22374707
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.
Goldman JL; Chung WH; Lee BR; Chen CB; Lu CW; Hoetzenecker W; Micheletti R; Yasuda SU; Margolis DJ; Shear NH; Struewing JP; Pirmohamed M
Eur J Clin Pharmacol; 2019 Aug; 75(8):1135-1141. PubMed ID: 30918988
[TBL] [Abstract][Full Text] [Related]
11. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
[TBL] [Abstract][Full Text] [Related]
12. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis.
Sassolas B; Haddad C; Mockenhaupt M; Dunant A; Liss Y; Bork K; Haustein UF; Vieluf D; Roujeau JC; Le Louet H
Clin Pharmacol Ther; 2010 Jul; 88(1):60-8. PubMed ID: 20375998
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
[TBL] [Abstract][Full Text] [Related]
14. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
[TBL] [Abstract][Full Text] [Related]
15. [Stevens-Johnson syndrome with transition to toxic epidermal necrolysis after carbamazepine administration, heroin and alcohol abuse].
Petter G; Haustein UF
Hautarzt; 1999 Dec; 50(12):884-8. PubMed ID: 10663024
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a Filipino with positive HLA-B75 serotype.
Capule F; Tragulpiankit P; Mahasirimongkol S; Wichukchinda N; Jittikoon J; Alentajan-Aleta LT; James Barit JV; Casanova-Gutierrez J; Cabral-Lim L; Baltazar Reyes JP; Roa F; San Gabriel KF; Silao CL
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30018035
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine--the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years.
Devi K; George S; Criton S; Suja V; Sridevi PK
Indian J Dermatol Venereol Leprol; 2005; 71(5):325-8. PubMed ID: 16394456
[TBL] [Abstract][Full Text] [Related]
18. Fatal toxic epidermal necrolysis associated with minoxidil.
Karaoui LR; Chahine-Chakhtoura C
Pharmacotherapy; 2009 Apr; 29(4):460-7. PubMed ID: 19323621
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
[TBL] [Abstract][Full Text] [Related]
20. The Co-Existence of Agranulocytosis and Stevens-Johnson Syndrome (SJS) in Carbamazepine Therapy: A Case Report.
Batool S; Voloshyna D; Usama M; Suleman M; Sandhu QI; Nepal L; Ghobriel NG; Mengar J; Mohammed Rasmy AS
Cureus; 2022 Sep; 14(9):e28917. PubMed ID: 36237740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
